Fighting Stigma Through Research

Image
Rebecca G. Baker, Ph.D.

Rebecca G. Baker, Ph.D., is the director of the NIH HEAL Initiative®Read more about Dr. Baker.

Dear HEAL Community,

Stigma is hard to talk about and hard to live with, and it’s a big problem for millions of people with pain or substance use disorders. Stigma occurs at multiple levels: affecting individuals, their healthcare providers, emergency responders, and even people in the recovery community. Stigma is rooted in stereotypes, prejudice, fear, and discrimination — all of which can be serious deterrents to implementing effective treatments for both pain and addiction.

People trying to manage chronic pain face formidable stigma. As one example, both patients and providers underuse opioid medications, even though these medications are known to be effective for certain conditions like chronic cancer pain. And despite ample evidence that addiction alters brain circuitry, fear of judgement from family and employers causes many people with opioid use disorder to avoid lifesaving treatments.

As a HEAL community, we must confront stigma within all these environments, and research is one powerful tool we have to guide these efforts. In many cases, we understand the problem but need proven ways to implement solutions for real people in real communities across America. Below are examples of how new HEAL research is addressing stigma:  

  • Determining whether stigma reduction training reduces provider stigma in a randomized controlled trial of the Opioid Wizard clinical decision-support tool to increase applications for buprenorphine waivers among primary care physicians? (Gavin Bart, M.D., Ph.D.)
  • Testing a behavioral economics approach that offers tangible rewards for uptake of treatment for opioid use disorder (Karen Derefinko, Ph.D.)
  • Developing mobile Health tools to assess and overcome stigma associated with opioid use disorder, seeking medical treatment for OUD, and mental health (Suzette Glasner-Edwards, Ph.D.)
  • Adapting HIV stigma-reduction approaches for use by people with chronic pain who are receiving hemodialysis (Manisha Jhamb, M.D., M.P.H.)
  • Conducting interviews with cancer survivors and their health providers to inform development of multi-level interventions to reduce stigma associated with chronic pain (Jane Liebschutz, M.D., M.P.H)
  • Involving peer recovery coaches to improve opioid use disorder treatment and services among low-income racial/ethnic minority populations (Jessica Magidson, Ph.D.)
  • Evaluating various types of stigma in people with opioid use disorder and chronic pain and developing psychotherapy approaches to address multidimensional stigma (Nora Nock, Ph.D.)
  • Testing use of antidepressant medications in people with chronic low back pain, depression, and anxiety, which can all trigger stigma (Ajay Wasan, M.D., M.Sc.)

As we await the findings from this research, one thing seems clear. Because so many factors create opportunities for stigma to persist, multi-level interventions will be needed to get rid of it. We welcome your insights about unraveling this solvable problem with continued diligence and creativity.

As always, share information about HEAL with your networks and remember that we want to hear from you. It just takes a quick email to [email protected]